(Q61917834)
Statements
SAFE (English)
0 references
A Swedish Multi-Centre, Prospective, Open Label Study: Safety of Avonex Treatment in Multiple Sclerosis Patients Who Are NAB Positive on Previous s.c Interferon Beta Therapy (English)
0 references
May 2004
0 references
May 2006
0 references
3
0 references
18 year
0 references
55 year
0 references